Bioidentical Hormones Market – Global Industry Analysis and Forecast (2023-2029)

Bioidentical Hormones Market is expected to grow at a CAGR of 5.29% during the forecast period. Bioidentical Hormones Market is expected to reach US$ 11.58 Bn. by 2029.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology:- Request Free Sample Report
Bioidentical Hormones Market Dynamics:
Bioidentical hormones are hormones that are chemically identical as those that the body produces. These hormones are used by women in Hormone Replacement Therapy (HRT) to ease the menopause symptoms such as hot flashes, reduced sex drive, vaginal dryness, night sweats, weight gain, fatigue, and mood change.

Rising screening tests for growth hormone deficiency analysis is majorly expected to drive the market growth. Improved screening for growth hormone deficiency using logical analysis data, worldwide rising female geriatric population, and growing awareness about technology related to bioidentical hormones therapy are expected to fuel the demand for bioidentical hormones in near future.

The presence of alternative treatments for HRT is anticipated to restrain the market growth in over the forecast period.
Alternatives to HRT such as tibolone, antidepressants, clonidine, and herbal remedies can affect the adoption of HRT treatments; hence, this is anticipated to hinder the market growth in the near future.
Bioidentical Hormones Market Segment Analysis:
The estrogen segment is expected to contribute a major market share over the forecast period due to abundant sources of plant estrogens coupled with rising demand for estrogen hormones such as estrone, estradiol, and estriol during HRT.
The tablet and capsule segment is expected to lead the market over the forecast period due to rising preference from patients towards convenient dosage form and ease of administration.
Bioidentical Hormones Market Regional Insights:
North America is expected to contribute substantial market share over next ten years owing to a surge in the number of HRTs, higher spending on healthcare, rapid uptake of bioidentical hormone products in the U.S., and the presence of major market players in the region.
Bioidentical Hormones Market Research Methodology:
The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply sides were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for the market.

Bioidentical Hormones Market, Key Highlights:

1. Bioidentical Hormones Market analysis and forecast, in terms of value.

2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the  Market

3. Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

4. Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

5. Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Market are also profiled.

The report has considered the base year of 2022 and past four years trend. 2022 figures are at actuals, however due to different dynamics of year 2022, market forecast is not only dependent upon 2022, but on the basis of 2018-2022.
Bioidentical Hormones Market Report Scope: Inquire before buying



Global Bioidentical Hormones Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US$ 8.07  Bn.


Forecast Period 2023 to 2029 CAGR:
5.29%
Market Size in 2029:
US$ 11.58 Bn.


 Segments Covered:
by Type
Estrogen
Progesterone
Testosterone
Other


by Product Type
Tablet & Capsule
Cream & Gel
Patch & Implant
Injectable
Other


by End-use
Hospital & Clinic
Academic & Research
Other



Bioidentical Hormones Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Bioidentical Hormones Market, Geographic Analysis:
1. Breakdown of North America Bioidentical Hormones market
2. Breakdown of Europe Bioidentical Hormones market
3. Breakdown of Asia Pacific Bioidentical Hormones market
4. Breakdown of Latin America Bioidentical Hormones market
5. Breakdown of MEA Bioidentical Hormones market
Bioidentical Hormones Market, Key Players:
1. BioTE Medical
2. NutraMarks, Inc.
3. SottoPelle
4. Advantage Pharmaceuticals, Inc.
5. Bravado Labs
6. Full Life Wellness Center
7. Neuva Aesthetics
8. Defy Medical
9. Biostation
10.United Pharmacy, LLC
11.TherapeuticsMD, Inc
12.NOVO NORDISK A/S
13.BAYER AG
14.Merck KgaA
15.Pfizer Inc.
16.Allergan
17.GeneScience Pharmaceuticals Co., Ltd.
18.SUPREMA.
19.INMODE
20.Noven Pharmaceuticals, Inc.
21.Defy Medical

Frequently Asked Questions:

1. Which region has the largest share in Global Bioidentical Hormones Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Bioidentical Hormones Market?
Ans: The Global Market is expected to grow at a CAGR of 5.29% during forecasting period 2023-2029.

3. What is scope of the Global market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global market?
Ans: The important key players in the Global Market are – BioTE Medical, NutraMarks, Inc., SottoPelle, Advantage Pharmaceuticals, Inc., Bravado Labs, Full Life Wellness Center, Neuva Aesthetics, Defy Medical, Biostation, United Pharmacy, LLC, TherapeuticsMD, Inc, NOVO NORDISK A/S, BAYER AG, and Merck KgaA.

5. What is the study period of this market?
Ans: The Global Market is studied from 2022 to 2029.